News &amp; Updates

A combination regimen comprising two herbal extracts – curcumin and Qing Dai (QD) – have shown potential in the treatment of active* ulcerative colitis (UC), according to two trials from Israel presented at Crohn’s & Colitis Congress (CCC) 2023.

Herbal combo regimen shows promise for ulcerative colitis

10 Feb 2023

Kisspeptin infusion may restore lost libido in men

An infusion of kisspeptin appears to be beneficial to men with hypoactive sexual desire disorder, modulating sexual brain processing, improving penile tumescence, and boosting sexual desire and arousal, as reported in a study.

Kisspeptin infusion may restore lost libido in men

NPC: Plasma EBV DNA cannot replace nasoendoscopy and biopsy during COVID-19 pandemic

Plasma Epstein-Barr virus (EBV) measurement, even when supplemented by imaging, cannot replace nasoendoscopy and biopsy in nasopharyngeal cancer (NPC) management during the COVID-19 pandemic, according to consensus recommendations by an international multidisciplinary group of experts.

NPC: Plasma EBV DNA cannot replace nasoendoscopy and biopsy during COVID-19 pandemic

Low HRQoL, anxiety up in kids, teens during COVID-19 pandemic

The three-wave longitudinal COPSY* study has shown that poor health-related quality of life (HRQoL), increased levels of anxiety, and other mental health problems have become more common among children and adolescents throughout the COVID-19 pandemic.

Low HRQoL, anxiety up in kids, teens during COVID-19 pandemic

Alcohol drinking blamed for rise in colorectal cancer cases among young adults

Consumption of alcohol appears to be a risk factor for early-onset colorectal cancer and has driven an increase in the incidence of colorectal cancer among young adults, as shown in a study.

Alcohol drinking blamed for rise in colorectal cancer cases among young adults

10 Feb 2023

Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab

In the treatment of hospitalized patients with COVID-19, survival outcomes appear to be more favourable with the 8-mg/kg tocilizumab regimen than with the fixed-dose tocilizumab regimen or sarilumab, according to a study.

Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab

09 Feb 2023

Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE

Young patients with newly diagnosed systemic lupus erythematosus (SLE) are vulnerable to psychiatric comorbidity, which tends to increase healthcare utilization, according to a study.

Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE

09 Feb 2023

Novel device safely delivers therapeutic compound in the colon

09 Feb 2023 by

Use of a novel drug delivery system (DDS) to deliver a therapeutic compound in the colon has been successful, achieving the intended function with no serious adverse events, reports a study presented at the recent Crohn’s & Colitis Congress (CCC 2023).

Novel device safely delivers therapeutic compound in the colon

Anti-MDA5 antibody–positive dermatomyositis with anti-Ro52 ups ILD, mortality risks

Patients with dermatomyositis (DM) who are positive for antimelanoma differentiation-associated gene 5 antibody (anti-MDA5) are more likely to have anti-Ro52 antibodies as well, and such coexistence appears to heighten the risks of rapidly progressive interstitial lung disease (ILD) and mortality, suggests a recent study.

Anti-MDA5 antibody–positive dermatomyositis with anti-Ro52 ups ILD, mortality risks

Gluten-free diet adherence suboptimal in individuals with celiac disease–IBD overlap

09 Feb 2023 by

Adherence to gluten-free diet (GFD) in individuals with celiac disease and inflammatory bowel disease (IBD) appears to be low, according to a study.

Gluten-free diet adherence suboptimal in individuals with celiac disease–IBD overlap